We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
SkinHealth Systems
SKIN
$90M
| $2.22K | ﹤0.01% |
1,160
-166,147
| -99% | -$234K |
|
1952
Vital Farms
VITL
$448M
| $2.2K | ﹤0.01% |
57
-27,104
| -100% | -$915K |
|
1953
Bioventus
BVS
$942M
| $2.19K | ﹤0.01% |
+331
| New | +$2.35K |
|
|
SCS
1954
DELISTED
Steelcase
SCS
| $2.19K | ﹤0.01% |
210
-64
| -23% | -$659 |
|
1955
IDT Corp
IDT
$1.71B
| $2.12K | ﹤0.01% |
+31
| New | +$1.78K |
|
1956
Preformed Line Products
PLPC
$2.06B
| $2.08K | ﹤0.01% |
13
| – | – |
|
1957
Dakota Gold
DC
$837M
| $2.03K | ﹤0.01% |
+549
| New | +$1.72K |
|
1958
eHealth
EHTH
$36.5M
| $1.97K | ﹤0.01% |
+452
| New | +$2.27K |
|
1959
OptimizeRx
OPRX
$147M
| $1.92K | ﹤0.01% |
+142
| New | +$1.55K |
|
1960
Tango Therapeutics
TNGX
$4.26B
| $1.85K | ﹤0.01% |
362
-7,221
| -95% | -$17.9K |
|
1961
SelectQuote
SLQT
$95.3M
| $1.84K | ﹤0.01% |
+775
| New | +$2.03K |
|
1962
Ponce Financial Group
PDLB
$491M
| $1.8K | ﹤0.01% |
+130
| New | +$1.68K |
|
1963
AudioEye
AEYE
$90.4M
| $1.75K | ﹤0.01% |
150
| – | – |
|
1964
Willis Lease Finance
WLFC
$1.17B
| $1.71K | ﹤0.01% |
36
| – | – |
|
|
KLRS
1965
Kalaris Therapeutics
KLRS
$97.6M
| $1.69K | ﹤0.01% |
634
| – | – |
|
1966
Alto Neuroscience
ANRO
$1.42B
| $1.68K | ﹤0.01% |
+765
| New | +$1.82K |
|
1967
Kura Oncology
KURA
$1.17B
| $1.68K | ﹤0.01% |
+291
| New | +$1.78K |
|
1968
Viridian Therapeutics
VRDN
$2.71B
| $1.66K | ﹤0.01% |
+119
| New | +$1.61K |
|
1969
Simply Good Foods
SMPL
$903M
| $1.64K | ﹤0.01% |
52
-29
| -36% | -$1.01K |
|
1970
LivePerson
LPSN
$34.4M
| $1.6K | ﹤0.01% |
106
-109
| -51% | -$1.29K |
|
|
FIRY
1971
Firy Inc
FIRY
$167M
| $1.56K | ﹤0.01% |
+229
| New | +$1.27K |
|
|
GOCO
1972
DELISTED
GoHealth
GOCO
| $1.53K | ﹤0.01% |
276
+145
| +111% | +$1.15K |
|
1973
Andersons Inc
ANDE
$2.17B
| $1.47K | ﹤0.01% |
40
-14
| -26% | -$513 |
|
1974
Mission Produce
AVO
$1.11B
| $1.45K | ﹤0.01% |
+124
| New | +$1.34K |
|
1975
Weis Markets
WMK
$1.74B
| $1.45K | ﹤0.01% |
20
-6
| -23% | -$470 |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.